Can inflammatory or oxidative stress make marginal vitamin B12 status less resilient in the nervous system?

Inflammation and oxidative stress are biologically capable of increasing tissue-injury, biosynthetic, and metabolic-adaptation pressures. Vitamin B12 supports two relevant enzymes—methionine synthase and methylmalonyl-CoA mutase—making the proposed interaction with nervous-system maintenance mechanistically credible, but not clinically established.

Mechanistic rationale

• B12-dependent methionine synthase helps maintain methionine and S-adenosylmethionine availability for methylation reactions. B12 deficiency can increase homocysteine and methylmalonic acid (MMA), while disrupting one-carbon and mitochondrial metabolism.
• Impaired methylation, MMA accumulation, altered lipid metabolism, mitochondrial dysfunction, and oxidative stress are plausible contributors to deficient myelin maintenance. Inflammatory or oxidative injury could increase repair-related biosynthetic demands and thereby reveal reduced metabolic reserve in a person with marginal B12 status.
• This remains an extrapolation: human studies have not directly shown that inflammatory or oxidative exposures increase B12-dependent one-carbon flux, B12 requirements, or neurologic injury specifically among people with marginal B12 status.

Clinical evidence and interpretation

• In asymptomatic older adults with moderate biochemical B12 deficiency, supplementation improved biochemical measures but did not improve neurologic or cognitive outcomes. Observational links between B12 status and neurologic function in older populations are limited and inconsistent.
• A low-normal serum B12 result does not reliably exclude clinically relevant deficiency. NICE considers serum B12 of 180–350 ng/L indeterminate and recommends considering MMA testing when neurologic symptoms are present.
• Neurologic symptoms should therefore prompt clinical assessment rather than reassurance based solely on a borderline or “normal” serum B12 concentration.

Bottom line

• The claim is plausible with moderate confidence: B12-related methylation and metabolic pathways provide a coherent basis for reduced neural resilience under inflammatory or oxidative stress, but direct human evidence demonstrating this stress–marginal-B12 interaction is lacking.